RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS INFECTIONS trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New nasal vaccine aims to protect kids from RSV
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new nasal spray vaccine (BLB-201) to prevent RSV, a common virus that can cause serious breathing problems in young children. About 137 infants and children aged 8 to 59 months will receive either the vaccine or a placebo. The goal is to check if the vaccine is…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Phase: PHASE1, PHASE2 • Sponsor: Blue Lake Biotechnology Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 31, 2026 00:00 UTC
-
New RSV vaccine trial aims to protect older adults
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine against respiratory syncytial virus (RSV) in adults. Phase I includes adults 18 and older to check safety of different doses. Phase II focuses on adults 60 and older to see how well the vaccine triggers an immune response and how safe it is. The vac…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Phase: PHASE1, PHASE2 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:37 UTC
-
New RSV drug trial aims to protect vulnerable adults
Disease control Recruiting nowThis study tests an experimental antiviral drug called S-337395 in adults with RSV who are at high risk for severe illness. Participants must have symptoms for less than 72 hours and a confirmed RSV infection. The goal is to see if the drug can lower the amount of virus in the bo…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Inhaled interferon could be new weapon against severe RSV in young children
Disease control Recruiting nowThis phase 3 trial tests whether an inhaled solution of human interferon α1b can safely help children under 2 years old recover from respiratory syncytial virus (RSV) lower respiratory tract infections. The study compares the interferon treatment to a placebo, measuring improveme…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Phase: PHASE3 • Sponsor: Kexing Biopharm Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New antiviral pill aims to shorten RSV symptoms in vulnerable adults
Disease control Recruiting nowThis study tests an oral antiviral called ziresovir (AK0529) in adults at high risk for severe RSV infection, such as those with chronic lung or heart disease, weakened immune systems, or age 65 and older. Participants receive either the drug or a placebo, and researchers measure…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Experimental 'Storm Stopper' therapy tested for COVID-19, flu, and RSV
Disease control Recruiting nowThis early-stage trial tests a new drug called PRS CK STORM, made from a mix of immune and fat cells, to see if it can safely calm the 'cytokine storm'—a dangerous overreaction of the immune system—in people with severe lung infections from COVID-19, flu, or RSV. The study will e…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Phase: PHASE1, PHASE2 • Sponsor: PEACHES BIOTECH • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a common antibiotic help kids breathe easier with severe RSV?
Disease control Recruiting nowThis study tests whether the antibiotic azithromycin can help children with severe RSV infection who need breathing support in the ICU. About 370 children will receive either azithromycin or a placebo for three days. The main goal is to see if the drug shortens the time they need…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Phase: PHASE3 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
RSV in elderly vietnamese patients: how big is the problem?
Knowledge-focused Recruiting nowThis study will track 1,000 adults aged 60 and older who are hospitalized in Vietnam with breathing problems or worsening heart/lung conditions. Researchers want to find out how many of these cases are caused by RSV (respiratory syncytial virus) and which types of the virus are i…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Sponsor: Tam Anh Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC